论文部分内容阅读
目的：评价对经皮黄疸仪检测值分组对诊治高胆红素血症的临床价值。方法对1200例高胆红素血症足月新生儿及婴儿，依据经皮黄疸胆仪检测值的高低进行分组，经皮胆红素测定值任意部位﹥13mg/dl为A组125例，﹥10~12.9mg/dl为B组468例，7~9.9mg/dl为C组421例，5~6.9mg/dl为D组186例，根据分组分别采取不同的治疗和干预措施，A组采用光疗及综合治疗，B组采用口服茵栀黄和枯草杆菌二联活菌颗粒（妈咪爱）治疗，C组口服妈咪爱治疗，D组未给予药物治疗仅进行日光浴和口服葡萄糖水处理。结果4组经治疗﹥12d后内经皮胆红素测定值降至﹤5mg/dl患者比例均﹥90%。结论经皮胆红素测定（经皮黄疸仪）值分组对诊治新生儿高胆红素血症有较高的临床实用价值。“,”Objective To evaluate the clinical value of percutaneous jaundice detection value grouping in the diagno-sis and treatment of hyperbilirubinemia. Methods 1 200 cases of full-term neonates and infants with hyperbilirubinemia were grouped according to the level of percutaneous biliary jaundice detection values. The transcutaneous bilirubin measurements at any site﹥13mg/dl was as group A(n=125 cases),﹥10 ~12. 9mg/dl as group B(n=468 cases),7 ~9. 9mg/dl as the group C(n=421 cases),5~6. 9mg/dl as the D group(n=186 cases). The treatment and intervention measures were taken according to different grouping. The group A received light therapy and combined therapy;the group B was treated with oral Yinzhihuang and Combined Bacillus Subtilis and Enterococcus Faecium Granules with Multivitamines,Live( MAMIAI)thera-py;the group C was given MAMIAI for treatment;the group D was not given drug treatment,but only for receiving sunbathing and oral glucose water treatment. Results After treatment for 12 days,the proportions of patients whose transcutaneous biliru-bin measurement value dropped to below 5mg/dl were all more than 90% in the 4 groups. Conclusion Percutaneous bilirubin ( transcutaneous jaundice meter)detection values grouping has high clinical value in the diagnosis of neonatal hyperbilirubi-nemia.